C3 and neoplasm: Collectively, the current literature on the role of complement in glioblastoma support an overall tendency of the tumor to suppress the activation of the C3 protein and downstream effectors, while simultaneously preserving the functions of the C1q opsonins necessary for enhanced immune tolerance during tumor progression.